Novavax COVID-19 Vaccine Granted Fast Track Designation by U.S. FDA
The Pharma Data
NOVEMBER 9, 2020
“While the regulatory review of this clinical program will be expedited, Novavax remains committed to a data-driven and scientifically rigorous approach in demonstrating safety and efficacy, which we believe will support confidence in the vaccine in the U.S. and globally.”. and Australia.
Let's personalize your content